molluscum%20contagiosum
MOLLUSCUM CONTAGIOSUM
Molluscum contagiosum is an infection due to poxvirus that results into discrete skin lesions with central umbilication.
Spread is by skin-to-skin contact, fomites spread and autoinoculation.
Patients with atopic dermatitis, HIV or immunodeficiency are particularly susceptible.
Incubation period may be from 2-7 weeks.
In children, it usually presents with lesions on the face, scalp, ears, trunk and extremities and crural folds while in adults, it is typically sexually transmitted and affects the groin, genital area, thighs and lower abdomen.

Introduction

  • Molluscum Contagiosum (MC) is an easily transmissible poxvirus
    • Spread is by skin-skin contact, fomites spread & autoinoculation
    • Patients w/ atopic dermatitis, HIV or immunodeficiency are particularly susceptible
  • Incubation may be from 2-7 wk

Signs and Symptoms

Clinical Presentation

Children

  • Usually present w/ lesions on the face, scalp, ears, trunk & extremities (axilla, antecubital, popliteal fossa) & crural folds
    • Genital presentation may have occurred from autoinoculation

Adults

  • MC is typically sexually-transmitted
  • MC affects the groin, genital area, thighs & lower abdomen
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Apr 2013
Aspergillus colonization may lead to an increase in the risk of bronchiolitis obliterans syndrome. This study determined the impact of colonization of conidia Aspergillus species after post lung transplantation.
5 days ago
No standard currently exists for the growing number of patients with multidrug-resistant strains of Helicobacter pylori, but a recent study has shown the safety and reliability of a 12-day low-dose rifabutin/high-dose proton pump inhibitor (PPI) regimen in patients infected with triple-resistant strains.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.

14 Jan 2018
Patients with a first episode of Clostridium difficile infection (CDI) are likely to respond to treatment with fidaxomicin with no recurrences, a recent study has shown. On the other hand, those with prior CDI episodes are less likely to respond, especially with >1 prior episode, and more likely to recur, which suggests a greater clinical benefit of fidaxomicin earlier in the course of CDI.